College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Department of Chemical and Biological Engineering, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
AAPS J. 2016 Sep;18(5):1168-1181. doi: 10.1208/s12248-016-9906-1. Epub 2016 May 16.
The aim of this work was to elucidate the structure-activity relationship of new peptide-modified gemini surfactant-based carriers. Glycyl-lysine modified gemini surfactants that differ in the length and degree of unsaturation of their alkyl tail were used to engineer DNA nano-assemblies. To probe the optimal nitrogen to phosphate (N/P) ratio in the presence of helper lipid, in vitro gene expression and cell toxicity measurements were carried out. Characterization of the nano-assemblies was accomplished by measuring the particle size and surface charge. Morphological characteristics and lipid organization were studied by small angle X-ray scattering technique. Lipid monolayers were studied using a Langmuir-Blodgett trough. The highest activity of glycyl-lysine modified gemini surfactants was observed with the 16-carbon tail compound at 2.5 N/P ratio, showing a 5- to 10-fold increase in the level of reporter protein compared to the 12 and 18:1 carbon tail compounds. This ratio is significantly lower compared to the previously studied gemini surfactants with alkyl or amino- spacers. In addition, the 16-carbon tail compound exhibited the highest cell viability (85%). This high efficiency is attributed to the lowest critical micelle concentration of the 16-tail gemini surfactant and a balanced packing of the nanoparticles by mixing a saturated and unsaturated lipid together. At the optimal N/P ratio, all nanoparticles exhibited an inverted hexagonal lipid assembly. The results show that the length and nature of the tail of the gemini surfactants play an important role in determining the transgene efficiency of the delivery system. We demonstrated here that the interplay between the headgroup and the nature of tail is specific to each series, thus in the process of rational design, the contribution of the latter should be assessed in the appropriate context.
这项工作的目的是阐明新型肽修饰双子表面活性剂载体的结构-活性关系。使用甘氨酰-赖氨酸修饰的双子表面活性剂来构建 DNA 纳米组装体,其烷基尾的长度和不饱和度不同。为了在存在辅助脂质的情况下探测最佳的氮磷比(N/P),进行了体外基因表达和细胞毒性测量。通过测量颗粒大小和表面电荷来完成纳米组装体的表征。通过小角 X 射线散射技术研究形态特征和脂质组织。使用 Langmuir-Blodgett 槽研究脂质单层。在 2.5 N/P 比下,16 碳尾化合物表现出甘氨酰-赖氨酸修饰双子表面活性剂的最高活性,与 12 和 18:1 碳尾化合物相比,报告蛋白的水平提高了 5-10 倍。与以前研究过的具有烷基或氨基间隔基的双子表面活性剂相比,这个比例显著降低。此外,16 碳尾化合物表现出最高的细胞活力(85%)。这种高效率归因于 16 尾双子表面活性剂的最低临界胶束浓度和通过混合饱和和不饱和脂质来平衡纳米颗粒的包装。在最佳 N/P 比下,所有纳米颗粒都表现出反相六方脂质组装。结果表明,双子表面活性剂的尾链的长度和性质在决定递送系统的转基因效率方面起着重要作用。我们在这里证明了头基和尾链性质之间的相互作用对于每个系列都是特定的,因此在合理设计的过程中,应该在适当的上下文中评估后者的贡献。